Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126793071 | 12679307 | 1 | I | 0 | 20160823 | 20160823 | DIR | 56.00 | YR | F | N | 180.00000 | LBS | 20160822 | N | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126793071 | 12679307 | 1 | PS | PRAVASTATIN SODIUM. | PRAVASTATIN SODIUM | 1 | Oral | 1 TABLET(S) AT BEDTIME TAKEN BY MOUTH | Y | D | 6A510154 | 20171031 | 0 | 1 | DF | COATED TABLET | HS | ||
| 126793071 | 12679307 | 3 | C | GLIMIPIRIDE | GLIMEPIRIDE | 1 | 0 | ||||||||||||
| 126793071 | 12679307 | 5 | C | PREMARIN | ESTROGENS, CONJUGATED | 1 | 0 | ||||||||||||
| 126793071 | 12679307 | 7 | C | SYNTHROID | LEVOTHYROXINE SODIUM | 1 | 0 | ||||||||||||
| 126793071 | 12679307 | 9 | C | METFORMIN | METFORMIN HYDROCHLORIDE | 1 | 0 | ||||||||||||
| 126793071 | 12679307 | 11 | C | VICTOZA | LIRAGLUTIDE | 1 | 0 | ||||||||||||
| 126793071 | 12679307 | 13 | C | AMLODIPINE | AMLODIPINE BESYLATE | 1 | 0 | ||||||||||||
| 126793071 | 12679307 | 15 | C | IRBESARTAN. | IRBESARTAN | 1 | 0 | ||||||||||||
| 126793071 | 12679307 | 17 | C | DARIFENACIN ER | 2 | 0 | |||||||||||||
| 126793071 | 12679307 | 19 | C | FISH OIL | FISH OIL | 1 | 0 | ||||||||||||
| 126793071 | 12679307 | 21 | C | VITAMIN D3 | CHOLECALCIFEROL | 1 | 0 | ||||||||||||
| 126793071 | 12679307 | 23 | C | VITAMIN B COMPLEX | CYANOCOBALAMINDEXPANTHENOLNIACINAMIDEPYRIDOXINE HYDROCHLORIDERIBOFLAVIN 5'-PHOSPHATE SODIUMTHIAMINE HYDROCHLORIDEVITAMIN B COMPLEX | 1 | 0 | ||||||||||||
| 126793071 | 12679307 | 25 | C | ASPIRIN. | ASPIRIN | 1 | 0 | ||||||||||||
| 126793071 | 12679307 | 27 | C | COLACE | DOCUSATE SODIUM | 1 | 0 | ||||||||||||
| 126793071 | 12679307 | 29 | C | GAVISCON | ALUMINUM HYDROXIDEMAGNESIUM CARBONATE | 1 | 0 | ||||||||||||
| 126793071 | 12679307 | 31 | C | ZEGRID | 2 | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 126793071 | 12679307 | 1 | Blood cholesterol increased |
Outcome of event
| no results found |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 126793071 | 12679307 | Arthralgia | |
| 126793071 | 12679307 | Asthenia | |
| 126793071 | 12679307 | Depression | |
| 126793071 | 12679307 | Gait disturbance | |
| 126793071 | 12679307 | Myalgia | |
| 126793071 | 12679307 | Suicidal ideation |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 126793071 | 12679307 | 1 | 8 | MON |